Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D for EVOMMUNE, INC. Common Stock, $0.0001 par value per share.
- Disclosed ownership: 11%.
- Date of event: 07 Nov 2025.
RA CAPITAL MANAGEMENT, L.P. - 07 Nov 2025 SCHEDULE 13D Report for EVOMMUNE, INC. Common Stock, $0.0001 par value per share
- Filing Manager
- RA CAPITAL MANAGEMENT, L.P.
- Reporting Manager
- RA Capital Management, L.P.
- Shares outstanding
- 31,443,364 shares
- Disclosed Ownership
- 3,458,770 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13D
- Filing time
- 17 Nov 2025, 16:44:09 UTC
- Date of event
- 07 Nov 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 11% ownership in EVOMMUNE, INC. Common Stock, $0.0001 par value per share on 07 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Nov 2025, 16:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 11% | 3,458,770 | 0 | 3,458,770 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | 0001346824 |
| Peter Kolchinsky | 11% | 3,458,770 | 0 | 3,458,770 | /s/ Peter Kolchinsky | Peter Kolchinsky | 0001384859 |
| Rajeev Shah | 11% | 3,458,770 | 0 | 3,458,770 | /s/ Rajeev Shah | Rajeev Shah | 0001619841 |
| RA Capital Healthcare Fund, L.P. | 8.5% | 2,674,425 | 0 | 2,674,425 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager | 0001315082 |